XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.3

Stockholders' Deficiency (Tables)

3 Months Ended

Sep. 30, 2025

Stockholders' Deficiency [Abstract]

Schedule of Warrants Outstanding

Warrants outstanding as of September 30, 2025 are as follows:

		Shares				Weighted Average Exercise Price*				Weighted Average Remaining Contractual Term (Years)
Outstanding at June 30, 2024			28			$	17,857				3.1
Granted			260,671				4.50				2.6
Adjustment*			399,215				(2.79	)
Exercised			(196,248	)			-				-
Outstanding at June 30, 2025			463,666				1.71				2.3
Granted			267,308				1.31				2.1
Adjustment*			452,007				(0.60	)
Outstanding at September 30, 2025 (Unaudited)			1,182,981			$	0.97				2.0

* Adjustment reflects the change in the number of shares issuable under the Purchase Warrant issued to Alumni Capital due to the contractual pricing mechanism based on outstanding shares. Upon any such price-based adjustment to the exercise price, the number of shares issuable upon exercise of the warrants will be adjusted proportionally

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration